Edition:
India

Recro Pharma Inc (REPH.OQ)

REPH.OQ on NASDAQ Stock Exchange Capital Market

8.93USD
19 Jan 2018
Change (% chg)

-- (--)
Prev Close
$8.93
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,805
52-wk High
$10.55
52-wk Low
$5.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 17.11 -0.475
Jun '17 16.93 -0.465
Mar '17 18.74 -0.425
FY 2016 Dec '16 17.36 -0.782
Sep '16 16.95 -0.499
Jun '16 17.28 -0.826
Mar '16 17.74 -0.707
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 16.08 18.25 13.90 --
Quarter Ending Jun-18 2 15.85 17.49 14.20 --
Year Ending Dec-18 3 66.11 71.00 63.60 71.69
Earnings (per share)
Quarter Ending Mar-18 2 -0.68 -0.67 -0.68 --
Quarter Ending Jun-18 2 -0.52 -0.51 -0.54 --
Year Ending Dec-18 3 -3.10 -2.05 -4.31 -2.27
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 33.46 -- --
EPS (TTM) % -912.65 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Recro Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 75.38%
# of Holders: 91
Total Shares Held: 14,416,487
3 Mo. Net Change: -573,335
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 8
# Reduced Positions: 3
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.